Pulling SEC filings + quote and writing the call…
FATE
FATE THERAPEUTICS INC
Next earnings Aug 10, 2026 · consensus $-0.27 EPS, $1.03M rev
Last earnings -5.1% on 2026-05-13
$2.18
▲ +4.21%$2.09▲ +68.55%
over 1Y
L $0.92EODHDH $2.84
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+4.2%
1W+6.1%
1M+10.6%
3M+93.5%
YTD+111.9%
1Y+68.5%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 18 analysts
Buy
Revenue fell -51.2% YoY.
FATE THERAPEUTICS INC shows $6.65M in FY2025 revenue (-51.2% YoY), a -2051.1% net margin, and -65.8% ROE.
Sources: SEC EDGAR (CIK 0001434316, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 5:45:41 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.